论文部分内容阅读
目的:分析莫西沙星联合氨溴索雾化吸入治疗老年肺炎的临床疗效。方法:收治的老年肺炎患者100例,随机分为观察组和对照组,观察组采用莫西沙星静脉滴注联合氨溴索雾化吸入治疗,对照组采用左氧氟沙星联合氨溴索静脉滴注治疗。结果:观察组平均热退时间、平均住院时间显著少于对照组(P<0.05);观察组治疗总有效率显著优于对照组(P<0.05);观察组治疗后病原菌清除率显著高于对照组(P<0.05)。结论:采用莫西沙星联合氨溴索雾化吸入治疗老年肺炎的临床疗效确切,能够提高治疗有效率,退热更快,住院时间更短。
Objective: To analyze the clinical effect of moxifloxacin and ambroxol inhalation in the treatment of senile pneumonia. Methods: 100 elderly patients with pneumonia were randomly divided into observation group and control group. The observation group was treated with moxifloxacin and ambroxol inhalation. The control group was treated with intravenous infusion of ambroxol and ambroxol. Results: The average back-off time and average length of hospital stay in the observation group were significantly less than those in the control group (P <0.05). The total effective rate in the observation group was significantly better than that in the control group (P <0.05). The clearance rate of pathogenic bacteria in the observation group was significantly higher Control group (P <0.05). Conclusion: Moxifloxacin combined with ambroxol nebulized inhalation for the treatment of senile pneumonia has definite curative effect, which can improve the curative effect, quicker fever-relief and shorter hospitalization time.